Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial
Yuzhou Huang, Miao Chen, Chen Yang, Jing Ruan, Shuqing Wang, Bing Han
Topics & Concepts
Refractory (planetary science)MedicineSirolimusGastroenterologyInternal medicineAdverse effectSurgeryBiologyAstrobiologyBlood disorders and treatmentsBlood groups and transfusionHematopoietic Stem Cell Transplantation